Wednesday 14 October 2015

Biosurgery Market by Type (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes), Application- Global Forecast to 2020

Biosurgery Market is expected to reach $25,635.01 million by 2020
Biosurgery products are used to aid surgeries and repair weakened and damaged tissues and bones of a body. The biosurgery market is majorly driven by the rising number of surgeries owing to the increasing rate of obesity and other lifestyle disorders, increasing participation in sports leading to sports-related injuries, and growing aging population. However, lack of reimbursement for these products and the increasing cost of surgical procedures are expected to restrain the growth of this market during the forecast period. 

The biosurgery market in this report is broadly segmented on the basis of type and application. On the basis of type, the market is segmented into sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents. On the basis of application, the market is segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopedic surgeries, thoracic surgeries, gynecology surgeries, urology surgeries, and reconstructive surgeries. 

The global biosurgery market is expected to reach $25,635.01 million by 2020, growing at a CAGR of 8.8% during the forecast period (2015 to 2020). Rising investments in R&D leading to development of innovative products in this space is propelling the growth of this market. Biosurgery products are finding increasing applications in neurological surgeries. 

Developed markets like North America and Europe will show sluggish growth, while emerging markets like Asia-Pacific and RoW (Latin America) are expected to witness strong growth during the forecast period. Growth in the Asia-Pacific and RoW markets will be majorly driven by countries such as China, Korea, Russia, and Brazil owing to the rising government investments in these countries, presence of a large patient population, and the increasing focus of leading players to capture growth opportunities in these markets. 

Some of the prominent players in this market include Baxter International Inc. (U.S.), C.R. Bard (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Sanofi Group (France), B. Braun Melsungen AG (Germany), Atrium Medical Corporation (U.S.), Cryolife, Inc. (U.S.), Stryker Corporation (U.S.), and Hemostasis, LLC (U.S.). Mergers and acquisitions, expansions, and new product launches are some of the strategies adopted by these players to sustain and enhance their presence in this market.

Reasons to Buy the Report: 

The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below-mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by top players in the biosurgery market. The report analyzes the biosurgery market by type and application
Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the biosurgery market
Market Development: Comprehensive information about lucrative emerging markets by product, application, and region
Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the biosurgery market
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, manufacturing capabilities, and SWOT analyses of leading players in the biosurgery market

Contact Us:

Contact No: +443330119100

No comments:

Post a Comment